Fredy Ariza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fredy Ariza has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Gustavo Adolfo Cruz Suarez
Anesthesiology Department, Fundación Valle del Lili, Cali, Colombia
3 shared publications - Mabel Moreno
Clinical Research Center, Fundacion Valle del Lili. Cali, Colombia
2 shared publications - Manuel Quintana-Díaz
Doctoral Program in Medicine and Surgery, University Autonomous of Madrid
2 shared publications - Philip Leib
Aortic Center Cleveland Clinic, Cleveland, OH; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH
2 shared publications - Akemi Arango
Clinical Research Center, Fundacion Valle del Lili. Cali, Colombia
1 shared publication - Alberto Federico García
Servicio de Cirugía de Trauma y Emergencias Fundación Valle del Lili Cali Colombia
1 shared publication
Latest Publications
- Open Access
- 10 November 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Perioperative Use of Prothrombin Complex Concentrates in Pediatric Cardiovascular Surgery: Protocol for a Scoping Review (HEART-PCC) (Preprint)
BACKGROUND Perioperative bleeding and hemostatic disturbances are major causes of morbidity and mortality in pediatric cardiovascular surgery, particularly in procedures requiring cardiopulmonary bypass, with the risk potentially shifting toward either hemorrhage or thrombosis. Prothrombin complex concentrates (PCCs) have emerged as a targeted hemostatic strategy because they allow rapid replacement of vitamin K–dependent coagulation factors and have been used as an alternative to plasma for factor replacement, although their use requires monitoring for thrombotic risk. While the evidence on PCCs has increased considerably in adult cardiovascular surgery, evidence in the pediatric population remains limited, heterogeneous, and derived primarily from observational studies. OBJECTIVE This scoping review aims to map and characterize the available evidence on the perioperative use of PCCs in pediatric cardiovascular surgery. METHODS This scoping review follows the JBI methodology and was prospectively registered in OSF Registries. Nine information sources were searched: PubMed/MEDLINE, CENTRAL, EMBASE, LILACS, Epistemonikos, MedRxiv, Google Scholar, ClinicalTrials.gov, and the World Health Organization repository. Studies published from January 1, 1990, involving patients younger than 18 years undergoing cardiac or great-vessel surgery for congenital or acquired heart disease, with or without cardiopulmonary bypass, in whom PCCs were used perioperatively for the management of bleeding or coagulopathy will be included. Title and abstract screening was performed independently by two reviewers blinded to each other's decisions in Rayyan. Full-text eligibility is assessed by a primary reviewer, with independent verification of all exclusions by a second reviewer, and data extraction is performed using a standardized form. Results will be synthesized descriptively and narratively, without meta-analysis or formal risk-of-bias assessment, and reported in accordance with the PRISMA-ScR extension. RESULTS Searches were conducted between July 22 and 29, 2026, and retrieved 226 records (PubMed/MEDLINE: 67; CENTRAL: 7; EMBASE: 99; LILACS: 1; Epistemonikos: 14; MedRxiv: 0; Google Scholar: 10; ClinicalTrials.gov: 23; World Health Organization: 5). Title and abstract screening has been completed, and full-text eligibility assessment and data extraction are ongoing. The review is expected to be completed in December 2026. CONCLUSIONS This scoping review will provide a structured map of the available evidence on the use of PCCs in pediatric cardiovascular surgery, describing populations, clinical indications, formulations, dosing regimens, monitoring strategies, reported outcomes, and thrombotic complications, and will identify evidence gaps that may inform future comparative studies and institutional hemostatic protocols. CLINICALTRIAL OSF Registries 10.17605/OSF.IO/AS7CB; https://doi.org/10.17605/OSF.IO/AS7CB
- 10 November 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPerioperative Use of Prothrombin Complex Concentrates in Pediatric Cardiovascular Surgery: Protocol for a Scoping Review (HEART-PCC) (Preprint)
BACKGROUND Perioperative bleeding and hemostatic disturbances are major causes of morbidity and mortality in pediatric cardiovascular surgery, particularly in procedures requiring cardiopulmonary bypass, with the risk potentially shifting toward either hemorrhage or thrombosis. Prothrombin complex concentrates (PCCs) have emerged as a targeted hemostatic strategy because they allow rapid replacement of vitamin K–dependent coagulation factors and have been used as an alternative to plasma for factor replacement, although their use requires monitoring for thrombotic risk. While the evidence on PCCs has increased considerably in adult cardiovascular surgery, evidence in the pediatric population remains limited, heterogeneous, and derived primarily from observational studies. OBJECTIVE This scoping review aims to map and characterize the available evidence on the perioperative use of PCCs in pediatric cardiovascular surgery. METHODS This scoping review follows the JBI methodology and was prospectively registered in OSF Registries. Nine information sources were searched: PubMed/MEDLINE, CENTRAL, EMBASE, LILACS, Epistemonikos, MedRxiv, Google Scholar, ClinicalTrials.gov, and the World Health Organization repository. Studies published from January 1, 1990, involving patients younger than 18 years undergoing cardiac or great-vessel surgery for congenital or acquired heart disease, with or without cardiopulmonary bypass, in whom PCCs were used perioperatively for the management of bleeding or coagulopathy will be included. Title and abstract screening was performed independently by two reviewers blinded to each other's decisions in Rayyan. Full-text eligibility is assessed by a primary reviewer, with independent verification of all exclusions by a second reviewer, and data extraction is performed using a standardized form. Results will be synthesized descriptively and narratively, without meta-analysis or formal risk-of-bias assessment, and reported in accordance with the PRISMA-ScR extension. RESULTS Searches were conducted between July 22 and 29, 2026, and retrieved 226 records (PubMed/MEDLINE: 67; CENTRAL: 7; EMBASE: 99; LILACS: 1; Epistemonikos: 14; MedRxiv: 0; Google Scholar: 10; ClinicalTrials.gov: 23; World Health Organization: 5). Title and abstract screening has been completed, and full-text eligibility assessment and data extraction are ongoing. The review is expected to be completed in December 2026. CONCLUSIONS This scoping review will provide a structured map of the available evidence on the use of PCCs in pediatric cardiovascular surgery, describing populations, clinical indications, formulations, dosing regimens, monitoring strategies, reported outcomes, and thrombotic complications, and will identify evidence gaps that may inform future comparative studies and institutional hemostatic protocols. CLINICALTRIAL OSF Registries 10.17605/OSF.IO/AS7CB; https://doi.org/10.17605/OSF.IO/AS7CB
- Open Access
- 23 July 2026
- Published by Sociedad Colombiana de Anestesiologia y Reanimacion (SCARE) in Colombian Journal of Anesthesiology
Neuromuscular blockade monitoring and antagonism practices: survey of Colombian Society of Anesthesiology and Resuscitation (S.C.A.R.E.) members
Introduction: Monitoring and reversal of neuromuscular blockade are essential to prevent adverse outcomes. Objective: To describe current neuromuscular blockade monitoring and reversal practices and to evaluate adherence to the 2023 American Society of Anesthesiologists (ASA) Task Force guidelines through a survey of anesthesiologists affiliated with the Colombian Society of Anesthesiology and Resuscitation (S.C.A.R.E.). Methods: A cross-sectional survey was distributed by S.C.A.R.E. to its active members via email between May-July 2024. The primary outcome was to describe neuromuscular blockade monitoring and antagonism practices and adherence to ASA guidelines. Analyses were primarily descriptive, with exploratory bivariate comparisons by years of professional experience and affiliation with residency training centers. Results: A total of 230 responses were collected. Rocuronium was the most used non-depolarizing agent (79.6%), and neostigmine the preferred reversal drug (73.9%). Clinical assessment predominated as the monitoring method (34.4%), while 31.7% lacked access to quantitative monitoring; 36.5% didn’t have access to sugammadex, citing high cost and administrative barriers. Anesthesiologists with ≤10 years of experience used sugammadex more often (54.7% vs. 27.6%, p < 0.001) and reversed minimal blockade with neostigmine at higher rates (57.9% vs. 35.1%, p = 0.001). Practice in training centers was associated with greater use of quantitative monitoring (42.9% vs. 18.0%, p < 0.001) and recognition of a TOF ratio of 0.9 as cutoff for residual blockade (83.9% vs. 63.3%, p = 0.005). Conclusion: Among S.C.A.R.E.-affiliated respondents, adherence to ASA 2023 recommendations remains limited. Improving access to monitoring, reducing barriers to sugammadex, and strengthening education are essential steps towards improving adherence.
- 23 July 2026
- Published by Sociedad Colombiana de Anestesiologia y Reanimacion (SCARE) in Colombian Journal of Anesthesiology
Open AccessNeuromuscular blockade monitoring and antagonism practices: survey of Colombian Society of Anesthesiology and Resuscitation (S.C.A.R.E.) members
Introduction: Monitoring and reversal of neuromuscular blockade are essential to prevent adverse outcomes. Objective: To describe current neuromuscular blockade monitoring and reversal practices and to evaluate adherence to the 2023 American Society of Anesthesiologists (ASA) Task Force guidelines through a survey of anesthesiologists affiliated with the Colombian Society of Anesthesiology and Resuscitation (S.C.A.R.E.). Methods: A cross-sectional survey was distributed by S.C.A.R.E. to its active members via email between May-July 2024. The primary outcome was to describe neuromuscular blockade monitoring and antagonism practices and adherence to ASA guidelines. Analyses were primarily descriptive, with exploratory bivariate comparisons by years of professional experience and affiliation with residency training centers. Results: A total of 230 responses were collected. Rocuronium was the most used non-depolarizing agent (79.6%), and neostigmine the preferred reversal drug (73.9%). Clinical assessment predominated as the monitoring method (34.4%), while 31.7% lacked access to quantitative monitoring; 36.5% didn’t have access to sugammadex, citing high cost and administrative barriers. Anesthesiologists with ≤10 years of experience used sugammadex more often (54.7% vs. 27.6%, p < 0.001) and reversed minimal blockade with neostigmine at higher rates (57.9% vs. 35.1%, p = 0.001). Practice in training centers was associated with greater use of quantitative monitoring (42.9% vs. 18.0%, p < 0.001) and recognition of a TOF ratio of 0.9 as cutoff for residual blockade (83.9% vs. 63.3%, p = 0.005). Conclusion: Among S.C.A.R.E.-affiliated respondents, adherence to ASA 2023 recommendations remains limited. Improving access to monitoring, reducing barriers to sugammadex, and strengthening education are essential steps towards improving adherence.
- Open Access
- 2 January 2024
- Published by Asociación Colombiana de Cirugía in Revista Colombiana de Cirugía
- Vol. 39 (1) , 113-121
Umbral crítico de administración en pacientes con trauma severo y reanimación endovascular: ¿Un concepto útil?
Introducción. Se describe la utilidad del umbral crítico de administración (CAT por su denominación en inglés) como herramienta para la reanimación hemostática en pacientes con trauma severo y oclusión endovascular aórtica. Métodos. Revisión retrospectiva de pacientes adultos con hemorragia por trauma, con o sin oclusión endovascular aórtica (REBOA), atendidos entre enero de 2015 y junio de 2020, en un centro de trauma nivel I en Cali, Colombia. Se registraron variables demográficas, severidad del trauma, estado clínico, requerimiento transfusional, tiempo hasta CAT+ y CAT alcanzado (1, 2 ó 3). Resultados. Se incluyeron 93 pacientes, se utilizó REBOA en 36 y manejo tradicional en 57. El grupo REBOA presentó mayor volumen de sangrado (mediana de 3000 ml, RIC: 1950-3625 ml) frente al grupo control (mediana de1500 ml, RIC: 700-2975ml) (p<0,001) y mayor cantidad de glóbulos rojos transfundidos en las primeras 6 horas (mediana de 5, RIC:4-9); p=0,015 y en las primeras 24 horas (mediana de 6, RIC: 4-11); p=0,005. No hubo diferencias estadísticamente significativas en número de pacientes CAT+ entre grupos o tiempo hasta alcanzarlo. Sin embargo, el estado CAT+ durante los primeros 30 minutos de la cirugía fue mayor en grupo REBOA (24/36, 66,7 %) frente al grupo control (17/57, 29,8 %; p=0,001), teniendo este mayor tasa de mortalidad intrahospitalaria frente a los pacientes CAT-. Conclusión. El umbral crítico de administración es una herramienta útil en la reanimación hemostática de pacientes con trauma y REBOA, que podría predecir mortalidad precoz.
- 2 January 2024
- Published by Asociación Colombiana de Cirugía in Revista Colombiana de Cirugía
- Vol. 39 (1) , 113-121
Open AccessUmbral crítico de administración en pacientes con trauma severo y reanimación endovascular: ¿Un concepto útil?
Introducción. Se describe la utilidad del umbral crítico de administración (CAT por su denominación en inglés) como herramienta para la reanimación hemostática en pacientes con trauma severo y oclusión endovascular aórtica. Métodos. Revisión retrospectiva de pacientes adultos con hemorragia por trauma, con o sin oclusión endovascular aórtica (REBOA), atendidos entre enero de 2015 y junio de 2020, en un centro de trauma nivel I en Cali, Colombia. Se registraron variables demográficas, severidad del trauma, estado clínico, requerimiento transfusional, tiempo hasta CAT+ y CAT alcanzado (1, 2 ó 3). Resultados. Se incluyeron 93 pacientes, se utilizó REBOA en 36 y manejo tradicional en 57. El grupo REBOA presentó mayor volumen de sangrado (mediana de 3000 ml, RIC: 1950-3625 ml) frente al grupo control (mediana de1500 ml, RIC: 700-2975ml) (p<0,001) y mayor cantidad de glóbulos rojos transfundidos en las primeras 6 horas (mediana de 5, RIC:4-9); p=0,015 y en las primeras 24 horas (mediana de 6, RIC: 4-11); p=0,005. No hubo diferencias estadísticamente significativas en número de pacientes CAT+ entre grupos o tiempo hasta alcanzarlo. Sin embargo, el estado CAT+ durante los primeros 30 minutos de la cirugía fue mayor en grupo REBOA (24/36, 66,7 %) frente al grupo control (17/57, 29,8 %; p=0,001), teniendo este mayor tasa de mortalidad intrahospitalaria frente a los pacientes CAT-. Conclusión. El umbral crítico de administración es una herramienta útil en la reanimación hemostática de pacientes con trauma y REBOA, que podría predecir mortalidad precoz.
- Open Access
- 17 November 2023
- Published by Sociedad Colombiana de Anestesiologia y Reanimacion (SCARE) in Colombian Journal of Anesthesiology
- Vol. 52 (1)
ChatGPT's learning and reasoning capacity in anesthesiology
Introduction: Over the past few months, ChatGPT has raised a lot of interest given its ability to perform complex tasks through natural language and conversation. However, its use in clinical decision-making is limited and its application in the field of anesthesiology is unknown. Objective: To assess ChatGPT’s basic and clinical reasoning and its learning ability in a performance test on general and specific anesthesia topics. Methods: A three-phase assessment was conducted. Basic knowledge of anesthesia was assessed in the first phase, followed by a review of difficult airway management and, finally, measurement of decision-making ability in ten clinical cases. The second and the third phases were conducted before and after feeding ChatGPT with the 2022 guidelines of the American Society of Anesthesiologists on difficult airway management. Results: On average, ChatGPT succeded 65% of the time in the first phase and 48% of the time in the second phase. Agreement in clinical cases was 20%, with 90% relevance and 10% error rate. After learning, ChatGPT improved in the second phase, and was correct 59% of the time, with agreement in clinical cases also increasing to 40%. Conclusions: ChatGPT showed acceptable accuracy in the basic knowledge test, high relevance in the management of specific difficult airway clinical cases, and the ability to improve after learning.
- 17 November 2023
- Published by Sociedad Colombiana de Anestesiologia y Reanimacion (SCARE) in Colombian Journal of Anesthesiology
- Vol. 52 (1)
Open AccessChatGPT's learning and reasoning capacity in anesthesiology
Introduction: Over the past few months, ChatGPT has raised a lot of interest given its ability to perform complex tasks through natural language and conversation. However, its use in clinical decision-making is limited and its application in the field of anesthesiology is unknown. Objective: To assess ChatGPT’s basic and clinical reasoning and its learning ability in a performance test on general and specific anesthesia topics. Methods: A three-phase assessment was conducted. Basic knowledge of anesthesia was assessed in the first phase, followed by a review of difficult airway management and, finally, measurement of decision-making ability in ten clinical cases. The second and the third phases were conducted before and after feeding ChatGPT with the 2022 guidelines of the American Society of Anesthesiologists on difficult airway management. Results: On average, ChatGPT succeded 65% of the time in the first phase and 48% of the time in the second phase. Agreement in clinical cases was 20%, with 90% relevance and 10% error rate. After learning, ChatGPT improved in the second phase, and was correct 59% of the time, with agreement in clinical cases also increasing to 40%. Conclusions: ChatGPT showed acceptable accuracy in the basic knowledge test, high relevance in the management of specific difficult airway clinical cases, and the ability to improve after learning.
- 16 August 2022
- Published by Wiley in Pediatric Anesthesia
- Vol. 32 (12) , 1372-1373
Four‐factor prothrombin complex concentrate in pediatric cardiac surgery for children under 8 kg: A short report
- 16 August 2022
- Published by Wiley in Pediatric Anesthesia
- Vol. 32 (12) , 1372-1373
Four‐factor prothrombin complex concentrate in pediatric cardiac surgery for children under 8 kg: A short report
- Open Access
- 13 May 2022
- Published by Sociedad Colombiana de Anestesiologia y Reanimacion (SCARE) in Colombian Journal of Anesthesiology
Advancing in the understanding of coagulopathy during hemorrhagic shock: From the triad to the deadly pentad
The deadly triad concept represented a dogma in the definition of poor outcomes and death associated with major bleeding in trauma. This model of end-stage disease was then rapidly transferred to other major bleeding scenarios. However, and notwithstanding the fact that it represented a severe scenario, the original triad fails to establish a sequence, which would be relevant when defining the objectives during the initial treatment of severe bleeding. It has been recently suggested that hypoxia and hyperglycemia should be included as isolated, determining factors in this model. Likewise, the model admits only one scenario where all the conditions shall co-exist, knowing that each one of them contributes with a different risk burden. Based on a structured review, we submit a pentad model that includes a natural pattern of events occurring with hypoxemia as the main trigger for the development of hypocalcemia, hyperglycemia, acidosis and hypothermia, as hallmarks of multiple system impairment. This severity model of major bleeding ends with coagulopathy as a result of the failure to resolve the rest of the previous components.
- 13 May 2022
- Published by Sociedad Colombiana de Anestesiologia y Reanimacion (SCARE) in Colombian Journal of Anesthesiology
Open AccessAdvancing in the understanding of coagulopathy during hemorrhagic shock: From the triad to the deadly pentad
The deadly triad concept represented a dogma in the definition of poor outcomes and death associated with major bleeding in trauma. This model of end-stage disease was then rapidly transferred to other major bleeding scenarios. However, and notwithstanding the fact that it represented a severe scenario, the original triad fails to establish a sequence, which would be relevant when defining the objectives during the initial treatment of severe bleeding. It has been recently suggested that hypoxia and hyperglycemia should be included as isolated, determining factors in this model. Likewise, the model admits only one scenario where all the conditions shall co-exist, knowing that each one of them contributes with a different risk burden. Based on a structured review, we submit a pentad model that includes a natural pattern of events occurring with hypoxemia as the main trigger for the development of hypocalcemia, hyperglycemia, acidosis and hypothermia, as hallmarks of multiple system impairment. This severity model of major bleeding ends with coagulopathy as a result of the failure to resolve the rest of the previous components.
- Open Access
- 1 February 2021
- Published by Taylor & Francis in Open Access Emergency Medicine
- Vol. ume 13, 67-73
Emergency Thrombolysis During Cardiac Arrest Due to Pulmonary Thromboembolism: Our Experience Over 6 Years
Introduction: Cardiac arrest (CA) is one of the leading causes of death worldwide. Among patients with CA, pulmonary embolism (PE) accounts for approximately 10% of all cases. Objective: To compare the outcomes after cardiopulmonary-cerebral resuscitation (CCPR) with and without thrombolytic therapy (TT) in patients with CA secondary to PE. Methods: We included patients older than 17 years admitted to our hospital between 2013 and 2017 with a diagnosis of CA with confirmed or highly suspected PE who received CCPR with or without TT. Measures of central tendency were used to depict the data. Results: The study comprised 16 patients, 8 of whom received CCPR and thrombolysis with alteplase, whereas the remaining patients received CCPR without TT. The most frequent rhythm of CA in both groups was pulseless electrical activity. Return of spontaneous circulation (ROSC) occurred in 100% of patients who received TT and in 88% of non-thrombolysed patients. The mortality rate of patients who received TT and non-thrombolysed patients at 24 hours was 25% and 50%, respectively. However, at the time of hospital discharge, the mortality was the same in both groups (62%). In patients who received TT, mortality was related to sepsis and hemorrhage whereas in non-thrombolysed patients, mortality was due to myocardial dysfunction. Conclusion: Intra-arrest thrombolysis resulted in a higher likelihood of ROSC and a higher 24-hour survival in adults with CA secondary to acute PE. Overall, the survival at hospital discharge was the same in the two groups.
- 1 February 2021
- Published by Taylor & Francis in Open Access Emergency Medicine
- Vol. ume 13, 67-73
Open AccessEmergency Thrombolysis During Cardiac Arrest Due to Pulmonary Thromboembolism: Our Experience Over 6 Years
Introduction: Cardiac arrest (CA) is one of the leading causes of death worldwide. Among patients with CA, pulmonary embolism (PE) accounts for approximately 10% of all cases. Objective: To compare the outcomes after cardiopulmonary-cerebral resuscitation (CCPR) with and without thrombolytic therapy (TT) in patients with CA secondary to PE. Methods: We included patients older than 17 years admitted to our hospital between 2013 and 2017 with a diagnosis of CA with confirmed or highly suspected PE who received CCPR with or without TT. Measures of central tendency were used to depict the data. Results: The study comprised 16 patients, 8 of whom received CCPR and thrombolysis with alteplase, whereas the remaining patients received CCPR without TT. The most frequent rhythm of CA in both groups was pulseless electrical activity. Return of spontaneous circulation (ROSC) occurred in 100% of patients who received TT and in 88% of non-thrombolysed patients. The mortality rate of patients who received TT and non-thrombolysed patients at 24 hours was 25% and 50%, respectively. However, at the time of hospital discharge, the mortality was the same in both groups (62%). In patients who received TT, mortality was related to sepsis and hemorrhage whereas in non-thrombolysed patients, mortality was due to myocardial dysfunction. Conclusion: Intra-arrest thrombolysis resulted in a higher likelihood of ROSC and a higher 24-hour survival in adults with CA secondary to acute PE. Overall, the survival at hospital discharge was the same in the two groups.
- Open Access
- 7 September 2020
- Published by Sociedad Colombiana de Anestesiologia y Reanimacion (SCARE) in Colombian Journal of Anesthesiology
- Vol. 48 (4)
Surgical site infection in adults undergoing major non-cardiac surgery and its association with anemia, severe bleeding and intraoperative transfusion: A preliminary report from a prospective registry
Introduction Surgical site infection (SSI) is among the most common healthcare-related infections. Given their greater morbidity and surgical complexity, patients undergoing major surgery are exposed to a high risk of SSI. Objective To determine the incidence of SSI in adult patients undergoing major elective non-cardiac surgery, and to identify risk factors associated with its occurrence within the first 30 days after surgery. Methods An analytical study was designed on the basis of a prospective institutional registry. Clinical and laboratory variables associated with perioperative management were recorded. An active search was conducted in order to find SSI episodes, renal failure and multiple organ dysfunction during the first 30 days after surgery. Adjusted logistic regression was done to identify potential associations between risk factors and the development of SSI. Results Overall, 1501 patients were included. The incidence of SSI during the first 30 days after surgery was 6.72% (95% CI 5.57-8.11). ASA III, abdominal surgery and longer procedures were more frequent in the SSI group. Association with the occurrence of SSI was documented for preoperative hemoglobin levels (adjusted OR 0.79 [95% CI 0.72-0.88], p = 0.04), intraoperative transfusion (adjusted OR 2,47 [95% CI 1.16-5.27], p = 0.02) and major blood loss (adjusted OR 3.80 [95% CI 1.63-8.88], p = 0.04). Conclusion Preoperative hemoglobin level, intraoperative transfusion and major bleeding are independent risk factors associated with the occurrence of SSI in adult patients undergoing major elective non-cardiac surgery.
- 7 September 2020
- Published by Sociedad Colombiana de Anestesiologia y Reanimacion (SCARE) in Colombian Journal of Anesthesiology
- Vol. 48 (4)
Open AccessSurgical site infection in adults undergoing major non-cardiac surgery and its association with anemia, severe bleeding and intraoperative transfusion: A preliminary report from a prospective registry
Introduction Surgical site infection (SSI) is among the most common healthcare-related infections. Given their greater morbidity and surgical complexity, patients undergoing major surgery are exposed to a high risk of SSI. Objective To determine the incidence of SSI in adult patients undergoing major elective non-cardiac surgery, and to identify risk factors associated with its occurrence within the first 30 days after surgery. Methods An analytical study was designed on the basis of a prospective institutional registry. Clinical and laboratory variables associated with perioperative management were recorded. An active search was conducted in order to find SSI episodes, renal failure and multiple organ dysfunction during the first 30 days after surgery. Adjusted logistic regression was done to identify potential associations between risk factors and the development of SSI. Results Overall, 1501 patients were included. The incidence of SSI during the first 30 days after surgery was 6.72% (95% CI 5.57-8.11). ASA III, abdominal surgery and longer procedures were more frequent in the SSI group. Association with the occurrence of SSI was documented for preoperative hemoglobin levels (adjusted OR 0.79 [95% CI 0.72-0.88], p = 0.04), intraoperative transfusion (adjusted OR 2,47 [95% CI 1.16-5.27], p = 0.02) and major blood loss (adjusted OR 3.80 [95% CI 1.63-8.88], p = 0.04). Conclusion Preoperative hemoglobin level, intraoperative transfusion and major bleeding are independent risk factors associated with the occurrence of SSI in adult patients undergoing major elective non-cardiac surgery.